logo

IMCC

IM Cannabis·NASDAQ
--
--(--)
--
--(--)
5.88 / 10
Netural

IM Cannabis's fundamentals score 5.9/10, indicating an average profile. Key positives include a healthy inventory turnover ratio (4.4483) and strong interest-coverage (15.5059%), which mitigate some risks. However, both total operating revenue and operating revenue are declining year-over-year (-4.0520%), and the net profit to total profit ratio is high (102.2643), suggesting potential data inconsistencies or one-off items. The stock's valuation factors (PB-ROE, Asset-MV, Revenue-MV, Profit-MV) show mixed signals, with only Cash-MV slightly positive. Overall, the company's fundamentals are neither compelling nor alarming, meriting a neutral rating.

Fundamental(5.88)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value1.60
Score2/3
Weight19.99%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value-4.05
Score1/3
Weight-0.84%
1M Return-0.60%
Inventory turnover ratio
Value4.45
Score2/3
Weight-1.67%
1M Return-1.23%
Profit-MV
Value0.47
Score3/3
Weight20.09%
1M Return10.40%
PB-ROE
Value-0.88
Score3/3
Weight23.24%
1M Return13.65%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-1.74%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value-4.05
Score1/3
Weight-0.73%
1M Return-0.52%
Asset-MV
Value-0.51
Score1/3
Weight16.63%
1M Return8.68%
Net profit / Total profit (%)
Value102.26
Score1/3
Weight-2.16%
1M Return-1.59%
Cash-MV
Value-0.07
Score3/3
Weight27.20%
1M Return12.04%
Is IMCC undervalued or overvalued?
  • IMCC scores 5.88/10 on fundamentals and holds a Fair valuation at present. Backed by its -98.94% ROE, -8.89% net margin, -6.44 P/E ratio, 2.19 P/B ratio, and 84.87% earnings growth, these metrics solidify its Netural investment rating.